These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

736 related articles for article (PubMed ID: 25702248)

  • 41. Multimodal Discrimination of Alzheimer's Disease Based on Regional Cortical Atrophy and Hypometabolism.
    Yun HJ; Kwak K; Lee JM;
    PLoS One; 2015; 10(6):e0129250. PubMed ID: 26061669
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The relative importance of imaging markers for the prediction of Alzheimer's disease dementia in mild cognitive impairment - Beyond classical regression.
    Teipel SJ; Kurth J; Krause B; Grothe MJ;
    Neuroimage Clin; 2015; 8():583-93. PubMed ID: 26199870
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Locally linear embedding (LLE) for MRI based Alzheimer's disease classification.
    Liu X; Tosun D; Weiner MW; Schuff N;
    Neuroimage; 2013 Dec; 83():148-57. PubMed ID: 23792982
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ensemble based on static classifier selection for automated diagnosis of Mild Cognitive Impairment.
    Nanni L; Lumini A; Zaffonato N
    J Neurosci Methods; 2018 May; 302():42-46. PubMed ID: 29104000
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Baseline and longitudinal patterns of brain atrophy in MCI patients, and their use in prediction of short-term conversion to AD: results from ADNI.
    Misra C; Fan Y; Davatzikos C
    Neuroimage; 2009 Feb; 44(4):1415-22. PubMed ID: 19027862
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sparse learning and stability selection for predicting MCI to AD conversion using baseline ADNI data.
    Ye J; Farnum M; Yang E; Verbeeck R; Lobanov V; Raghavan N; Novak G; DiBernardo A; Narayan VA;
    BMC Neurol; 2012 Jun; 12():46. PubMed ID: 22731740
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predicting conversion from MCI to AD with FDG-PET brain images at different prodromal stages.
    Cabral C; Morgado PM; Campos Costa D; Silveira M;
    Comput Biol Med; 2015 Mar; 58():101-9. PubMed ID: 25625698
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modelling prognostic trajectories of cognitive decline due to Alzheimer's disease.
    Giorgio J; Landau SM; Jagust WJ; Tino P; Kourtzi Z;
    Neuroimage Clin; 2020; 26():102199. PubMed ID: 32106025
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Classification of Mild Cognitive Impairment With Multimodal Data Using Both Labeled and Unlabeled Samples.
    Yuan S; Li H; Wu J; Sun X
    IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(6):2281-2290. PubMed ID: 33471765
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clustering-induced multi-task learning for AD/MCI classification.
    Suk HI; Shen D
    Med Image Comput Comput Assist Interv; 2014; 17(Pt 3):393-400. PubMed ID: 25320824
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Deep learning reveals Alzheimer's disease onset in MCI subjects: Results from an international challenge.
    Amoroso N; Diacono D; Fanizzi A; La Rocca M; Monaco A; Lombardi A; Guaragnella C; Bellotti R; Tangaro S;
    J Neurosci Methods; 2018 May; 302():3-9. PubMed ID: 29287745
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Using machine learning to quantify structural MRI neurodegeneration patterns of Alzheimer's disease into dementia score: Independent validation on 8,834 images from ADNI, AIBL, OASIS, and MIRIAD databases.
    Popuri K; Ma D; Wang L; Beg MF
    Hum Brain Mapp; 2020 Oct; 41(14):4127-4147. PubMed ID: 32614505
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cortical graph neural network for AD and MCI diagnosis and transfer learning across populations.
    Wee CY; Liu C; Lee A; Poh JS; Ji H; Qiu A;
    Neuroimage Clin; 2019; 23():101929. PubMed ID: 31491832
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aberrant Connectivity in Mild Cognitive Impairment and Alzheimer Disease Revealed by Multimodal Neuroimaging Data.
    Li Q; Wu X; Xie F; Chen K; Yao L; Zhang J; Guo X; Li R;
    Neurodegener Dis; 2018; 18(1):5-18. PubMed ID: 29334684
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantitative evaluation of disease progression in a longitudinal mild cognitive impairment cohort.
    Runtti H; Mattila J; van Gils M; Koikkalainen J; Soininen H; Lötjönen J;
    J Alzheimers Dis; 2014; 39(1):49-61. PubMed ID: 24121959
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Multivariate Data Analysis and Machine Learning for Prediction of MCI-to-AD Conversion.
    Skolariki K; Terrera GM; Danso S
    Adv Exp Med Biol; 2020; 1194():81-103. PubMed ID: 32468526
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Classification of Alzheimer's Disease and Mild Cognitive Impairment Based on Cortical and Subcortical Features from MRI T1 Brain Images Utilizing Four Different Types of Datasets.
    Toshkhujaev S; Lee KH; Choi KY; Lee JJ; Kwon GR; Gupta Y; Lama RK
    J Healthc Eng; 2020; 2020():3743171. PubMed ID: 32952988
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of Feature Selection Techniques in Machine Learning for Anatomical Brain MRI in Dementia.
    Tohka J; Moradi E; Huttunen H;
    Neuroinformatics; 2016 Jul; 14(3):279-96. PubMed ID: 26803769
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prediction of Incipient Alzheimer's Disease Dementia in Patients with Mild Cognitive Impairment.
    Ardekani BA; Bermudez E; Mubeen AM; Bachman AH;
    J Alzheimers Dis; 2017; 55(1):269-281. PubMed ID: 27662309
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel joint HCPMMP method for automatically classifying Alzheimer's and different stage MCI patients.
    Sheng J; Wang B; Zhang Q; Liu Q; Ma Y; Liu W; Shao M; Chen B
    Behav Brain Res; 2019 Jun; 365():210-221. PubMed ID: 30836158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.